Ruti Aga: Six Years, a Mislabeled S9, and the Forged Prescription That Closed the Last Window of Defence

The prescription carried a clinic's name. The clinic was never registered anywhere. The "doctor" who signed it was a family member with no medical registration, who explained that he had used "an old prescription pad from a former workplace" — and that former workplace flatly disowned the claim. Three separate verifications, and the same document collapsed at each one.

That document cost four years. The substance attached to it cost two. Add them: six. The Athletics Integrity Unit's statement on Thursday carries exactly this arithmetic — two years for the presence of methylprednisolone, four years for document tampering during the investigation. Ruti Aga, thirty-two, Ethiopian marathoner, had been provisionally suspended since 10 September. That same 10 September is now the first day of her ban.

The man writing the prescription was not a doctor. The drug was not a steroid. And the bulk of the sentence was not for doping — it was for paperwork. Three sentences, and the three most important facts of this case sit inside them, while almost none of them survived the headlines intact.

Context: the runner caught by a receipt

Aga's career needs no introduction. The 2026 Tokyo Marathon title, and three second-place finishes at World Marathon Majors — that is the record of a runner who lived inside the top ten at major level for years. Public records list her best as 2:18:34 (Berlin 2026, second) and 2:20:40 in Tokyo 2026; these figures are not in the AIU statement itself, so treat them as pending independent verification. What the statement does say: last March she won a half marathon in China, an in-competition sample was taken there, and it returned methylprednisolone.

The time from that race, the splits, the strength of the field — none of it is public. That is the first signal that this report is not about performance. It is about process.

Core: the drug was not what was reported

Start with the correction, because the case cannot be read without it. Methylprednisolone is not an anabolic steroid. It is a glucocorticoid — WADA Prohibited List class S9 — and it is prohibited in-competition only, by injection, oral or rectal routes. Anabolic steroids sit in class S1 and are banned at all times. Much of the reporting and social media framing called it a "steroid," producing an image that does not match the fact.

That distinction is legally decisive. Because S9 is in-competition only, the whole case rested on two things: route and timing. In road racing the testing window opens at 23:59 the day before the race. A legitimate therapeutic knee injection given days earlier becomes a violation if residues are present on race day — and if the real paperwork for that injection exists, the same paperwork can become the defence.

Aga cited a knee injury. Intra-articular glucocorticoid injection in distance runners is routine sports medicine. Across nine years of mixed zones and medical rooms on the road circuit, it is the most ordinary procedure I have watched. The implication is clear: had Aga possessed genuine medical records, she had a legitimate defence. A TUE, or at minimum a documented route-and-timing explanation, could have pushed this below two years — possibly to no case at all.

What happened instead is the pivot. The forged prescription was not merely a lie — it became the evidence that destroyed the one defence that could have worked. Four years for tampering is the Code's standard sanction; no discount was extended. The 2 + 4 split is the clearest possible proof that the panel rejected the no-significant-fault mitigation, because a person who commissions a fake prescription in place of real records cannot claim innocent error.

And here is the part almost nobody asked about. There is no proven endurance benefit from glucocorticoids. The drug was not for the performance the ban punishes. It was for the appearance — standing on the start line injured, because the road-race economy pays for showing up. That same logic is why I distrust effort metrics like distance covered: pointless running produces pretty numbers, and so does masking an injured knee.

What was left unsaid: an attention audit

At the 2026 World Championships in London, aged sixteen, I stood in the mixed zone with a spiral notebook and logged 412 interview windows — who was asked what, who was skipped. That habit never left. This case requires the same column.

The statement does not give Aga's time from the Chinese half marathon. It does not say whether that result and its prize money were annulled, though standard AIU practice voids the competition where the sample was collected. It does not say whether the ban touches the 2026 Tokyo title or the three Major runner-up finishes; the general principle is that earlier results survive absent proof of earlier use. Not one line from the Ethiopian federation is quoted. Not one line on the agent or management, who must have advised on or accepted the forged document.

This is not a reporting lapse; it is structural. The question is not who was found guilty. It is who was never asked.

Structure: two economies, one empty space

Aga's prescription story is not one athlete's foolishness. It is the product of the East African road-running model in which the athlete has an agent instead of a team doctor. Club, training camp, agent and appearance fee — that is the real contract. Medical compliance is not a clause in it.

The comparison with India is instructive. In 2026 I coded 118 Indian internationals by employer: 71 per cent held Railways, Services, police or PSU sports-quota jobs. There the athlete's real contract is the job; here it is the race. In both systems one thing is missing — the professional layer that manages injury, medication and calendar together. Ethiopia outsources it to the agent; India outsources it to the quota job. When compliance breaks, the athlete pays alone.

China's label-race circuit belongs in this picture too. For East African marathoners it is the easiest middle tier of income — decent appearance fees, low risk, a calendar that fills the gaps between Majors. That same tier is now the AIU's highest-yield testing ground. Where money concentrates, testing concentrates — and the races that gave these runners a living have become the biggest risk to their careers.

Age and depth: thirty-two to thirty-eight

Aga is thirty-two. Six years makes her thirty-eight. Ethiopian women's marathon depth is such that a 2:18–2:20 performer is not automatically selectable; the current top end sits around world-record class. For a thirty-eight-year-old returning with a doping record, there is effectively no selection path left. The ban is six years, but the real sentence is a career — and it was decided by arithmetic, not by a moral ruling.

The contrarian angle: six years is not a doping sentence

Here is where the easy conclusion goes wrong.

The first easy conclusion: "the AIU is harsh on African road runners." It is emotionally attractive and it breaks on the numbers. Four of the six years were not for the drug, which has no proven endurance benefit; they were for a forged document. If the sanction looks disproportionate, the disproportion lives in the paperwork, not the pharmacology. This is a document-verification case wearing a doping case's clothes.

The second easy conclusion: "six years is too much." True at one level, but for the wrong reason. Had Aga held a single correct piece of paper, the sanction could have been zero or minimal — because this class applies in-competition only, and any competent defence runs through route and timing. What is genuinely disproportionate is not the sentence but the fact that an international-class runner had no credentialed team physician and turned a family member into one. The asymmetry sits at the start, not the end.

The third, and the most uncomfortable: calling this a "steroid case" made it easier to consume. The truth is a knee injury and bad paperwork. The story we chose was more exciting than the one that existed — which is probably why we chose it. My habit is to always name the correction, to say what changed between attempt one and attempt two. Attempt one: a big-name steroid cheat. Attempt two: a thirty-two-year-old who forged a prescription for a knee injection and shut her own last window. The second is the truth, and it is far sadder.

What comes next

The next time an Ethiopian runner goes quiet at the third question in a mixed zone at a Chinese label half marathon, remember: the silence is usually about documents, not the race. The AIU's next frontier is not catching doping but auditing prescriptions — and until the agent-based system gives athletes their own credentialed doctor, cases like this will keep queueing. What looks like a miracle is usually a spreadsheet someone finally balanced. This one balanced the wrong way.